Cardiff Oncology, Inc.

CRDF · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$11-$14-$13-$12
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$0$1$1
Change in WC-$1$4-$1$0
Other Non-Cash-$0$1-$0-$0
Operating Cash Flow-$11-$8-$13-$10
Investing Activities
PP&E Inv.-$0-$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$9-$20-$35$0
Inv. Sales/Matur.$20$15$21$5
Other Inv. Act.$0$0-$1$0
Investing Cash Flow$10-$5-$15$5
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$44
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$44
Forex Effect$0-$0$0$0
Net Chg. in Cash-$1-$13-$27$38
Supplemental Information
Beg. Cash$11$24$51$13
End Cash$10$11$24$51
Free Cash Flow-$11-$8-$13-$10